The global laboratory information systems market was is valued at $1.8bn in 2017 and is expected to grow at a CAGR of 8.3% from 2018 to 2028. In 2017, the software segment held 71% of the global laboratory information systems market.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Laboratory Information Systems Market outlook from 2018-2028
• Global Laboratory Information Systems Submarkets analysis and forecast from 2018-2028, by delivery: • Web-based • On-Premise based • Cloud-based
• Global Laboratory Information Systems Submarkets analysis and forecast from 2018-2028, by application: • Clinical • Drug Discovery • Industrial
• Global Laboratory Information Systems Submarkets analysis and forecast from 2018-2028, by component: • Software • Hardware • Services
• This report provides individual revenue forecasts from 2018-2028 for these regional and national markets: • North America: US, Canada, Mexico • Europe: UK, Germany, France, Rest of Europe • Asia-Pacific: Japan, China, India, Rest of Asia-Pacific • Rest of the World (RoW)
• Our study discusses the selected leading companies that are the major players in the laboratory information systems market: • Abbott Laboratories • Cerner Corporation • Eclipsys Corporation • LabVantage Solutions, Inc. • LabWare, Inc. • McKesson Corporation • Medical Information Technology, Inc. • Thermo Fisher Scientific
• This report provides a Porter’s Five Forces Analysis of the global laboratory information systems market.
Visiongain’s study is intended for anyone requiring commercial analyses for the biologics market. You find data, trends and predictions.
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.
The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.
Visiongain Publishes Antigen Skin Test Market Report to 2031
The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing health concerns among population and growing incidences of fungal & bacterial infection are some of the factors driving the growth of Antigen Skin Test market.
Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.
Visiongain Publishes Anti-Infective Vaccines Market Report Report to 2031
The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market.